R N Kalaria Selected Research

R N Kalaria Research Topics

Disease

9	Dementia (Dementias) 06/2012 - 01/2001
6	CADASIL 10/2013 - 01/2002
5	Alzheimer Disease (Alzheimer's Disease) 08/2012 - 04/2000
5	Stroke (Strokes) 11/2010 - 07/2001
4	Hypertension (High Blood Pressure) 09/2009 - 11/2004
3	Cognitive Dysfunction 01/2009 - 10/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2013 - 06/2012
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 06/2012 - 04/2006
2	Inflammation (Inflammations) 01/2012 - 10/2000
2	Atrophy 01/2009 - 10/2007
2	Orthostatic Hypotension (Postural Hypotension) 06/2007 - 09/2006
2	Amyloid Plaque 05/2001 - 01/2001
1	Delirium 01/2015
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2013
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 02/2011
1	Fibrosis (Cirrhosis) 02/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2010
1	Hippocampal Sclerosis 10/2007
1	Autonomic Nervous System Diseases (Dysautonomia) 06/2007
1	Multiple System Atrophy 06/2007
1	Parkinsonian Disorders (Parkinsonism) 06/2007
1	Ganglion Cysts (Ganglion) 09/2006
1	Synucleinopathies 09/2006
1	Hypersensitivity (Allergy) 09/2006
1	Hypoxia (Hypoxemia) 07/2006
1	Sleep Wake Disorders 12/2005
1	Hallucinations (Hallucination) 12/2005
1	REM Sleep Behavior Disorder 12/2005
1	Hyperlipidemias (Hyperlipidemia) 11/2004
1	Hyperhomocysteinemia 11/2004
1	Leukoencephalopathies 08/2004
1	Major Depressive Disorder (Major Depressive Disorders) 11/2002
1	Vascular Depression 11/2002
1	Gliosis 11/2002
1	Diabetes Mellitus 07/2001
1	Atrial Fibrillation 07/2001
1	Aphasia (Dysphasia) 07/2001
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2001
1	Ischemia 10/2000

Drug/Important Bio-Agent (IBA)

3	Amyloid beta-PeptidesIBA 10/2013 - 04/2000
2	Proteins (Proteins, Gene)FDA Link 10/2013 - 11/2010
2	Amyloid (Amyloid Fibrils)IBA 10/2013 - 08/2012
2	Peptides (Polypeptides)IBA 08/2012 - 04/2006
2	Cholinergic Agents (Cholinergics)IBA 06/2012 - 07/2001
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012 - 10/2000
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2010 - 07/2001
2	Pemetrexed (MTA)FDA Link 01/2009 - 10/2007
2	ApolipoproteinsIBA 07/2001 - 01/2001
1	Prion ProteinsIBA 10/2013
1	PrionsIBA 10/2013
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 06/2012
1	AntibodiesIBA 06/2012
1	ThrombomodulinIBA 01/2012
1	InterleukinsIBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2011
1	Collagen Type IV (Type IV Collagen)IBA 02/2011
1	High-Temperature Requirement A Serine Peptidase 1IBA 02/2011
1	Retinaldehyde (Retinal)IBA 02/2011
1	Excitatory Amino AcidsIBA 11/2010
1	Vesicular Glutamate Transport Protein 1IBA 11/2010
1	Vesicular Glutamate Transport ProteinsIBA 11/2010
1	SynaptophysinIBA 11/2010
1	hydroxide ionIBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 02/2007
1	CollagenIBA 02/2007
1	alpha-SynucleinIBA 09/2006
1	ElementsIBA 09/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2006
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2006
1	Drinking WaterIBA 07/2006
1	EstersIBA 07/2006
1	Antipsychotic Agents (Antipsychotics)IBA 12/2005
1	Levodopa (L Dopa)FDA LinkGeneric 12/2005
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2005
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2005
1	Apolipoprotein E4IBA 09/2005
1	Antiphospholipid AntibodiesIBA 11/2004
1	Lipoprotein(a)IBA 11/2004
1	Apolipoproteins E (ApoE)IBA 10/2004
1	Formaldehyde (Formol)FDA Link 08/2004
1	Glial Fibrillary Acidic ProteinIBA 11/2002
1	NucleotidesIBA 01/2002
1	Biological FactorsIBA 07/2001
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2001
1	Presenilin-1IBA 05/2001
1	APP717IBA 05/2001

Therapy/Procedure

3	Therapeutics 10/2013 - 01/2001
1	Critical Care (Surgical Intensive Care) 01/2015
1	Immunotherapy 10/2013
1	Witchcraft (Sorceries) 09/2009
1	Massage (Zone Therapy) 09/2006
1	Secondary Prevention 10/2004